RNAscope™ Spatial Biology Grant Program

Any Gene. Any Species. Any Tissue.

Advanced Cell Diagnostics, a brand of Bio-Techne, is proud to announce the 2022 RNAscope Grant Program for Spatial Biology. The goal of this program is to support innovative research studies designed to advance the understanding of life.

See the “Where” for every “What” by revealing the cellular and sub-cellular location in tissues.

Understand the “Why” by digging deeper.

RNAscope is the gold standard in RNA tissue imaging, backed by over 5,000 research publications. Enabling interrogation of up to 12 different RNA targets in a single FFPE tissue section or up to 48 targets in fixed-frozen or fresh frozen samples, you can easily visualize just the genes you want in any tissue or organism. With access to over 40,000 catalog probes and fast, custom probe design, you can answer your next questions with confidence. If you don’t have access to a histology or imaging core, that’s fine too. RNAscope can be easily performed in your lab using a standard fluorescent microscope.

Often used as a complement to RNAseq, single cell sequencing (scRNA-seq), and spatial profiling applications, with RNAscope you can:

• Easily resolve heterogenous tissues at single-cell and sub-cellular resolution.
• Identify spatial and functional cellular relationships within the tissue microenvironment.
• Determine the importance of gene expression signatures in disease pathology.
• Visualize low-expressing or difficult biomarkers with single-molecule sensitivity.

Submission is easy. Just send a short summary describing how you would propose using RNAscope to advance your research goals. Winning entries will receive a RNAscope detection kit (along with appropriate probe sets, controls, and sample prep reagents) to support their research project free of charge. Award recipients will be announced by September 16, 2022.

Terms & Conditions

Terms & Conditions
By submitting your entry, you agree to these terms for yourself and on behalf of your Institution/Company. “You” and “your” shall refer to you personally or your Institution/Company, as applicable. “We,” “Us,” or “Our” includes Advanced Cell Diagnostics (ACD) and Bio-Techne and/or its officers, employees, directors, agents, and affiliates. If you do not agree to these terms, do not click the “SUBMIT” box above, and do not participate in this offer.

Contest terms:
1) One entry only per individual. Once you have submitted your entry, you may not amend it. Applications must be submitted by September 2, 2022 to qualify.

2) Qualified entries will be judged by a team of ACD and Bio-Techne scientists for appropriateness and completeness in response. Each entry will be judged based on our view of how well the entry reflects scientific merit, innovation, and fit with RNAscope technology.

3) Successful grant applicants will receive 1 RNAscope HiPlex v2 kit, and sufficient probes, controls, and ancillary products free of charge to support their spatial expression project based on the grant proposal project description, subject to approval of the experimental plan by ACD.

4) Grant award winners agree to make their RNAscope HiPlex v2 datasets available for confidential internal review by ACD within 120 days following notification of winning an award.

5) Grant winners agree to be available for reasonable promotional activities at ACD’s request for a period of nine months following announcement of a prize award. Promotional activities may include, but are not limited to:

• Assisting ACD in preparation of a case study based on the project
• Participating in ACD webinars
• Being featured as a researcher in an ACD Spotlight/Website/Newsletter story
• Participating in virtual or in-person seminars
• Image release

6) You agree to obtain all authorizations and permissions from your Institution/Company or others that are required to allow you to make this submission and to have your name and the name of your institution used for all purposes, including marketing, by ACD or its affiliates without any compensation and with or without attribution, regardless of whether yours is judged to be a winning entry. You also agree personally to all the authorizations and permissions required by these terms and conditions.

7) You agree that the use of your submission by ACD does not violate any rule, policy, copyright, trademark, patent, or procedures of your Institution/Company or that of any other person. Participation in submission does not implead on intellectual property of the results.

8) You acknowledge and agree that any submission made hereunder is not being made in exchange for any promise of providing business to ACD.

9) You agree that ACD may contact you for purposes of marketing its products and services.

10) ACD reserves the right to discontinue or modify this program at any time for any reason. In such event, ACD will notify and inform all already-submitted entrants via e-mail. In the event of discontinuance or modification of the program, this will not result in ACD having any liability to you, your employees, agents, or team members for such discontinuance or modification.

11) ACD may refuse to consider a submission if ACD determines in its sole discretion that awarding the prize to the entrant would likely result in a violation of an applicable law, rule, or policy, including, but not limited to, whether awarding a prize would be contrary to the law where you reside or work.

12) IN NO EVENT SHALL ACD, ITS OFFICERS, DIRECTORS, EMPLOYEES, OR AGENTS, BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES WHATSOEVER ARISING UNDER OR AS A RESULT OF ENTRANCE IN OR PARTICIPATION IN THE OFFER, WHETHER BASED ON WARRANTY, CONTRACT, TORT, STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT ACD IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE FOREGOING LIMITATION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY LAW.